HIGHLIGHTS
- who: Alloxan and collaborators from the Department of BiochemistryDepartment of Biochemistry have published the research: anti-hyperglycemic properties for cardiac tissue during diabetes_mellitus, in the Journal: (JOURNAL)
- what: A dose of alloxan 150 mg/kg body weight was chosen in this study as up to 140-200 mg/kg body weight alloxan doses were reported to non lethal. This study shows that Momordica charantia and Trigonella foenum graecum exhibit antiperoxidative and antioxidant activities in heart tissue of alloxan induced diabetic rats by decreasing the levels of lipid peroxidation products and increasing the levels/activities of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.